IP-based Technology Transfer
Our objective is to develop a resolution
that satisfies every requirement of clients.
IP-based Technology Transfer
Our objective is to develop a resolution
that satisfies every requirement of clients.
대표이사 소개
CEO
- 학력
-
- 서울대학교 약학대학 약학과 졸업
- 대구가톨릭대학교 대학원 약학박사
- 미국 University of New Hampshire School of Law , Juris Doctor
- 주요경력
-
- 미국 Davis & Bujold, PLLC 근무
- 미국 AGG Intellectual Property Law 근무
- 성균관대학교 제약산업학과 초빙교수
- 보건의료기술정책 심의위원회 전문위원
- 한국거래소 코스닥상장위원회 심의위원
- 現 명진 국제특허법률사무소 대표변리사
- 現 주식회사 엠제이엘 바이오 대표이사
- 現 KSBMB 산학위원
- 現 한국여성벤처협회 부회장
- 자격사항
-
- 한국변리사
- 미국변리사 (미국 특허청 Patent Bar)
- 미국변호사 (뉴욕주, 매사추세츠주)
- 기술거래사
- 약사
- 주요저서
-
- 바이오기술계약총서 (2015, IPMS)
- Education
-
- B.S. Department of Pharmacy, College of Pharmacy, Seoul National University, Korea
- Ph.D. in Molecular Genetics, Catholic University of Daegu, Korea
- J.D., University of New Hampshire School of Law, Concord, NH, U.S.A
- Career Highlights
-
- Davis & Bujold, PLLC in NH, U.S.A.
- AGG Intellectual Property Law in MA, U.S.A
- Department of Pharmaceutical Industry in SungKyunKwan University, Visiting Professor
- Member of Korea Exchange, KOSDAQ Listing Commission Board
- MJ International Patent Law Firm, Managing Partner (Present)
- MJL Bio. Co., Ltd. CEO (Present)
- Industry-Academia Committee Member, KSBMB (Present)
- Vice President, KOVWA (Present)
- Certification
-
- Admitted to Korean Patent Bar
- Admitted to Massachusetts Bar
- Admitted to United States Patent and Trademark Office
- Admitted to New York Bar
- Technology Transfer Agent
- Pharmacist
- Major Publications
-
- Contracts for Technology Transfer in Biotechnology (2015, IPMS).
대표이사 이명진(LEE, MYOUNG-JIN)
약학박사/법학박사
한국변리사/미국변호사/미국변리사
기술거래사/약사
Myoung-Jin Lee
Ph.D., Juris Doctor
Korean Patent Attorney
Counselor at Law (NY, MA)
Pharmacist
Technology Transfer Agent
주요 연혁
Key Milestones
2016년
2016
- MJL BIO 설립
- Establishment of MJL BIO
2020년
2020
- 산업통상자원부 기술거래기관 지정
- Designated as a Technology Transfer Institutions by the Ministry of Trade, Industry and Energy
2023년
2023
- KOTRA/중소벤처기업진흥공단수출지원기반 활용사업 수행기관
- 한국보건산업진흥원 /보건산업 기술가치평가 조사분석 수행기관
- 한국특허전략원 /스타트업 지식재산바우처사업 수행기관
- 홍릉강소특구 / 지식재산컨설팅 수행기관
- 서울대학교 병원 /기술거래중개기관
- TIPS 운용사 컨소시엄(주관:한국기술가치투자)
- KOTRA/SMEs Export Support Program - Implementing Organization
- Korea Health Industry Development Institute - Health Industry Technology Value Assessment
- Korea Patent Strategy Institute - Startup Intellectual Property Voucher Program
- Hongneung Small Enterprise Cluster - Intellectual Property Consulting
- Seoul National University Hospital - Technology Transfer Institutions
- TIPS Consortium Manager (Korea Technology Value Investment)
2024년
2024
- 서울대학교 병원/글로벌마케팅 용역사업 수행기관
- 아주대학교/글로벌마케팅 용역사업 수행기관
- 알트메디칼/글로벌마케팅 용역사업 수행기관
- 분당서울대병원 올해의 기술사업화 최우수 파트너사 선정
- Seoul National University Hospital - Global Marketing Service Implementation
- Ajou University - Global Marketing Service Implementation
- AltMedical - Global Marketing Service Implementation
- Bundang Seoul National University Hospital - Selected as the Best Partner for Technology Commercialization
주요 업무
Key Services
글로벌 기술 사업화
전문화된 글로벌 네트워크를 활용하여 기술마케팅, 창업지원, 비즈니스 모델 수립 등 맞춤형 글로벌 사업화 컨설팅을 수행합니다.
- 유망기술, 수요기업 발굴
- 온오프라인 기술마케팅
- 국내외 기술이전 협상 및 법률서비스
- 비즈니스 모델 수립
기술사업화 전략 고도화
기술사업화 전략 고도화 서비스는 시장 경쟁력을 강화하고 성공적인 비즈니스 성과를 창출하기 위한 맞춤형 전략을 제공합니다.
- SMK 작성 (기초, 심화, 고도화 3단계)
- 경쟁기업 및 제품 우위 분석
- 제품 포지셔닝/시장 진입 전략 수립 지원
기술가치평가/특허분석
사업타당성분석, 기술가치평가 및 침해분석(FTO)을 수행합니다.
- 기술가치평가
- 사업타당성 분석
- FTO(침해분석)
IP-R&BD
IP, 기술환경 분석을 위한 R&BD기획, R&BD 단계별 IP 전략 수립을 제공합니다.
- 경쟁환경 및 기술 동향 분석
- R&BD 기획 및 전략 수립
- 특허 포트폴리오 구축
Global Technology
Transfer &
Commercialization
We provide customized global consulting services in technology marketing, startup support, business model development, and more, by leveraging a professional global network
- Discovering emerging technologies & potential partners
- On/Off-line technology marketing
- Tech transfer negotiations & legal services (domestic & international)
- Business model development
Technology
Commercialization
Strategy Enhancement
The services for enhancing technology commercialization strategies are tailored to improve market competitiveness and achieve successful business results.
- SMK Development (Basic, In-depth, Advanced)
- Competitor evaluation & product advantage analysis
- Supporting product positioning & go-to-market strategy development
Technology
Valuation/
Patent Analysis
We conduct technology value assessments, business feasibility evaluation, and FTO (Freedom to Operate) analysis.
- Technology Value Assessment
- Business Feasibility evaluation
- FTO (Infringement Analysis)
IP-R&BD
We provide R&D and IP strategy development for technology environmental analysis and R&BD planning.
- Competitive environment and technology trend analysis
- R&D planning and strategy development
- Patent portfolio development
바이오·제약 분야 글로벌 마케팅 이력
Global Marketing Experience in the Bio-Pharma Field
해외 기술전시회 참석
2012년부터
15회 이상
파트너링 매칭 기업
200여개 이상
Merck, BoehringerIngelheim, Bayer 등
글로벌 빅파마 포함
해외 마케팅 기술
50여건 이상
암, 대사질환, 신경질환,피부질환, 안질환 등
다수 혁신 신약 기술
수요기업 DB
6,000개 이상
질환 분야별 누적 DB
Over
15 Exhibitions Attended
Since 2012
More than 200 Partnering Companies
including global big pharma such as Merck, Boehringer Ingelheim, and BayerMore than 50 Global Marketing Technologies
covering areas like cancer, metabolic diseases, neurological diseases, dermatological diseases, ophthalmic diseases, and other innovative new drug technologiesOver 6,000 Potential Partners Database
categorized by disease area| No | 주요 행사명 | 일시 | 장소 |
|---|---|---|---|
| No | Major Event Names | Dates | Locations |
| 1 |
LES(USA & CANADA) 2012 Annual Meeting Connecting+ Collaborating |
2012. 10 | Toronto, Canada |
| 2 | BIO Asia International Conference | 2013. 01 | Tokyo, Japan |
| 3 | BIO Europe 2016 Spring | 2016. 04 | Stockholm, Sweden |
| 4 | BIO Europe 2016 Fall | 2016. 11 | Cologne, Germany |
| 5 | BIO Europe 2017 Spring | 2017. 03 | Barcelona, Spain |
| 6 | BIO Europe 2017 Fall | 2017. 11 | Berlin, Germany |
| 7 | BIO Europe 2018 Spring | 2018. 03 | Amsterdam, Netherlands |
| 8 | BIO Europe 2018 Fall | 2018. 11 | Copenhagen, Denmark |
| 9 | BIO Europe 2019 Spring | 2019. 03 | Vienna, Austria |
| 10 | AusBiotech 2019 | 2019. 10 | Melbourne, Australia |
| 11 | BIO Europe 2020 Fall | 2020. 10 | Online |
| 12 | BIO Europe 2022 Fall | 2022. 10 | Leipzig, Germany |
| 13 | BIO International Convention (BIO USA) 2023 | 2023. 06 | Boston, USA |
| 14 | BIO Europe 2023 Fall | 2023. 11 | Munich, Germany |
| 15 | BIO International Convention (BIO USA) 2024 | 2024. 06 | San Diego, USA |
| 16 | BIO Europe 2024 Fall | 2024. 11 | Stockholm, Sweden |
MJL BIO 글로벌 네트워크
Our Global Network
- Genentech & Roche
- Mayo Clinic
- BioCentury
- DMC EDA
- Skyhawk Therapeutics
- Escient Pharma
- Alira Health
- Graviton Bioscience
- Contineum
- Dermaliq Therapeutics
- Plexus Ventures
- Lacerta Bio
- OmniSync
- RUMI Scientific
- Bioviida
- Ventoux Bio
- CALDWELL
- Aribio USA
United States
- Bayer
- Boehringer Ingelheim
- Merck
- Tiefenbacher
- Pentixapharm
- VPM
- Ascenion
- DESY
- Maiwald
- Biosaxony
- Bioscience Valuation
- Bioseet
- FHR Consult
Germany
- CR Sanjiu
- Simcere
- Biocytogen
- Jiangsu CTFP
- Reistone
- Sironax
- ApicHope
China
- Ellipses Pharma
- Evaluate
- PharmaVentures
- Sage Group
- ImmuPharma
- Valirx
- Phaim Pharma
United Kingdom
- JT Pharma
- KAKEN
- Maruho
- Teikoku
- Nagoya University
- 88 Therapeutics
- TAGCyx
- Seuju Pharma
- R-NanoBio
- Tech Manage
- Swanielle
Japan
- Partner Intl
- Domain Therapeutics
- Mannin Research
- Shadow Lake
Canada
- Debiopharm
- Asceneuron
- Venture Valuation
- LatticePoint
Switzerland
- Sun Pharma
- SPARC
- ICPA
India
- Owkin
- Théa Innovation
- SATT
- Cenponts
France
- NLO BV
- Treeway
- Liberi Group
Netherlands
- IOCB Tech
- i&I Prague
Czech Republic
- United States
- Germany
- Japan
- China
- United Kingdom
- Canada
- France
- Switzerland
- India
- Netherlands
- Czech Republic
- Australia
- Israel
- Austria
- Italy
- Belgium
- Mexico
- Denmark
- Poland
- Ireland
오시는길
CONTACT
서울특별시 강남구 테헤란로 445, 13층 (삼성동, 본솔빌딩)
13th Floor, Bonsol Building, 445, Teheran-ro, Gangnam-gu, Seoul, 06158, Rep. of KOREA
- phone_enabled TEL
- +82-2-558-5864
- fax FAX
- +82-2-558-5865
- mail E-MAIL
- mjlee@mjlbio.com